Sanara MedTech Inc. (NASDAQ:SMTI) has caught the attention of Yi Chen from H.C. Wainwright, who has set a bullish price target of $54. This projection indicates a potential upside of approximately 81.94% for the stock currently priced at $29.68.

The recent Q2 2025 earnings call showcased the company’s robust financial performance and innovative strategies aimed at future growth.

Despite experiencing a daily decrease of 2.37%, the stock’s yearly variance reflects considerable investor interest amid cautious optimism.